Polyphosphate and tyrosine phosphorylation in the N-terminal domain of the human mitochondrial Lon protease disrupts its functions.


Journal

Scientific reports
ISSN: 2045-2322
Titre abrégé: Sci Rep
Pays: England
ID NLM: 101563288

Informations de publication

Date de publication:
30 04 2024
Historique:
received: 18 12 2023
accepted: 18 04 2024
medline: 1 5 2024
pubmed: 1 5 2024
entrez: 30 4 2024
Statut: epublish

Résumé

Phosphorylation plays a crucial role in the regulation of many fundamental cellular processes. Phosphorylation levels are increased in many cancer cells where they may promote changes in mitochondrial homeostasis. Proteomic studies on various types of cancer identified 17 phosphorylation sites within the human ATP-dependent protease Lon, which degrades misfolded, unassembled and oxidatively damaged proteins in mitochondria. Most of these sites were found in Lon's N-terminal (NTD) and ATPase domains, though little is known about the effects on their function. By combining the biochemical and cryo-electron microscopy studies, we show the effect of Tyr186 and Tyr394 phosphorylations in Lon's NTD, which greatly reduce all Lon activities without affecting its ability to bind substrates or perturbing its tertiary structure. A substantial reduction in Lon's activities is also observed in the presence of polyphosphate, whose amount significantly increases in cancer cells. Our study thus provides an insight into the possible fine-tuning of Lon activities in human diseases, which highlights Lon's importance in maintaining proteostasis in mitochondria.

Identifiants

pubmed: 38688959
doi: 10.1038/s41598-024-60030-9
pii: 10.1038/s41598-024-60030-9
doi:

Substances chimiques

Protease La EC 3.4.21.53
Polyphosphates 0
Tyrosine 42HK56048U

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

9923

Subventions

Organisme : Grantová Agentura České Republiky
ID : 894 Grant No. 1825144Y
Organisme : Grantová Agentura České Republiky
ID : 894 Grant No. 1825144Y
Organisme : Grantová Agentura České Republiky
ID : 894 Grant No. 1825144Y
Organisme : Interreg
ID : StruBioMol, ITMS: 305011X666
Organisme : Interreg
ID : StruBioMol, ITMS: 305011X666
Organisme : Interreg
ID : StruBioMol, ITMS: 305011X666
Organisme : Interreg
ID : StruBioMol, ITMS: 305011X666
Organisme : Interreg
ID : StruBioMol, ITMS: 305011X666
Organisme : European Regional Development Fund, European Union
ID : UP CIISB (No. CZ.02.1.01/0.0/0.0/18_046/0015974)
Organisme : European Regional Development Fund, European Union
ID : UP CIISB (No. CZ.02.1.01/0.0/0.0/18_046/0015974)
Organisme : European Regional Development Fund
ID : BIOMEDIRES - II. stage, ITMS: 313011W428
Organisme : Agentúra na Podporu Výskumu a Vývoja
ID : APVV-15-0375, APVV-19-0298
Organisme : Agentúra na Podporu Výskumu a Vývoja
ID : APVV-15-0375, APVV-19-0298
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : 2/0069/23
Organisme : Vedecká Grantová Agentúra MŠVVaŠ SR a SAV
ID : 2/0069/23

Informations de copyright

© 2024. The Author(s).

Références

Kruse, R. & Hojlund, K. Mitochondrial phosphoproteomics of mammalian tissues. Mitochondrion 33, 45–57. https://doi.org/10.1016/j.mito.2016.08.004 (2017).
doi: 10.1016/j.mito.2016.08.004 pubmed: 27521611
Lucero, M., Suarez, A. E. & Chambers, J. W. Phosphoregulation on mitochondria: Integration of cell and organelle responses. CNS Neurosci. Ther. 25, 837–858. https://doi.org/10.1111/cns.13141 (2019).
doi: 10.1111/cns.13141 pubmed: 31025544 pmcid: 6566066
Pinti, M. et al. Emerging role of Lon protease as a master regulator of mitochondrial functions. Biochim. Biophys. Acta 1300–1306, 2016. https://doi.org/10.1016/j.bbabio.2016.03.025 (1857).
doi: 10.1016/j.bbabio.2016.03.025
Gibellini, L. et al. The biology of Lonp1: More than a mitochondrial protease. Int. Rev. Cell Mol. Biol. 354, 1–61. https://doi.org/10.1016/bs.ircmb.2020.02.005 (2020).
doi: 10.1016/bs.ircmb.2020.02.005 pubmed: 32475470
Matsushima, Y., Goto, Y. & Kaguni, L. S. Mitochondrial Lon protease regulates mitochondrial DNA copy number and transcription by selective degradation of mitochondrial transcription factor A (TFAM). Proc. Natl. Acad. Sci. U S A 107, 18410–18415. https://doi.org/10.1073/pnas.1008924107 (2010).
doi: 10.1073/pnas.1008924107 pubmed: 20930118 pmcid: 2972957
Pinti, M. et al. Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer. Cell Mol. Life Sci. 72, 4807–4824. https://doi.org/10.1007/s00018-015-2039-3 (2015).
doi: 10.1007/s00018-015-2039-3 pubmed: 26363553
Ngo, J. K. & Davies, K. J. Mitochondrial Lon protease is a human stress protein. Free Radic. Biol. Med. 46, 1042–1048. https://doi.org/10.1016/j.freeradbiomed.2008.12.024 (2009).
doi: 10.1016/j.freeradbiomed.2008.12.024 pubmed: 19439239 pmcid: 3093304
Pinti, M. et al. Functional characterization of the promoter of the human Lon protease gene. Mitochondrion 11, 200–206. https://doi.org/10.1016/j.mito.2010.09.010 (2011).
doi: 10.1016/j.mito.2010.09.010 pubmed: 20933102
Ghosh, J. C. et al. Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits. Oncogene 38, 6926–6939. https://doi.org/10.1038/s41388-019-0939-7 (2019).
doi: 10.1038/s41388-019-0939-7 pubmed: 31406245 pmcid: 6814529
Wlodawer, A., Sekula, B., Gustchina, A. & Rotanova, T. V. Structure and the mode of activity of lon proteases from diverse organisms. J. Mol. Biol. 434, 167504. https://doi.org/10.1016/j.jmb.2022.167504 (2022).
doi: 10.1016/j.jmb.2022.167504 pubmed: 35183556 pmcid: 9013511
Botos, I. et al. The catalytic domain of Escherichia coli Lon protease has a unique fold and a Ser-Lys dyad in the active site. J. Biol. Chem. 279, 8140–8148. https://doi.org/10.1074/jbc.M312243200 (2004).
doi: 10.1074/jbc.M312243200 pubmed: 14665623
Baker, T. A. & Sauer, R. T. ATP-dependent proteases of bacteria: Recognition logic and operating principles. Trends Biochem. Sci. 31, 647–653. https://doi.org/10.1016/j.tibs.2006.10.006 (2006).
doi: 10.1016/j.tibs.2006.10.006 pubmed: 17074491 pmcid: 2717004
Cheng, I. et al. Identification of a region in the N-terminus of Escherichia coli Lon that affects ATPase, substrate translocation and proteolytic activity. J. Mol. Biol. 418, 208–225. https://doi.org/10.1016/j.jmb.2012.02.039 (2012).
doi: 10.1016/j.jmb.2012.02.039 pubmed: 22387465
Shin, M. et al. Structures of the human LONP1 protease reveal regulatory steps involved in protease activation. Nat. Commun. 12, 3239. https://doi.org/10.1038/s41467-021-23495-0 (2021).
doi: 10.1038/s41467-021-23495-0 pubmed: 34050165 pmcid: 8163871
Kereiche, S. et al. The N-terminal domain plays a crucial role in the structure of a full-length human mitochondrial Lon protease. Sci. Rep. 6, 33631. https://doi.org/10.1038/srep33631 (2016).
doi: 10.1038/srep33631 pubmed: 27632940 pmcid: 5025710
Mohammed, I. et al. Catalytic cycling of human mitochondrial Lon protease. Structure 30, 1254–1268. https://doi.org/10.1016/j.str.2022.06.006 (2022).
doi: 10.1016/j.str.2022.06.006 pubmed: 35870450
Gesé, G. V. et al. A dual allosteric pathway drives human mitochondrial Lon. bioRxiv https://doi.org/10.1101/2021.06.09.447696 (2021).
doi: 10.1101/2021.06.09.447696
Tzeng, S. R. et al. Molecular insights into substrate recognition and discrimination by the N-terminal domain of Lon AAA+ protease. Elife 10, e64056. https://doi.org/10.7554/eLife.64056 (2021).
doi: 10.7554/eLife.64056 pubmed: 33929321 pmcid: 8087443
Hornbeck, P. V. et al. PhosphoSitePlus, 2014: Mutations, PTMs and recalibrations. Nucleic Acids Res. 43, D512-520. https://doi.org/10.1093/nar/gku1267 (2015).
doi: 10.1093/nar/gku1267 pubmed: 25514926
Li, J. et al. A chemical and phosphoproteomic characterization of dasatinib action in lung cancer. Nat. Chem. Biol. 6, 291–299. https://doi.org/10.1038/nchembio.332 (2010).
doi: 10.1038/nchembio.332 pubmed: 20190765 pmcid: 2842457
Bai, Y. et al. Phosphoproteomics identifies driver tyrosine kinases in sarcoma cell lines and tumors. Cancer Res. 72, 2501–2511. https://doi.org/10.1158/0008-5472.CAN-11-3015 (2012).
doi: 10.1158/0008-5472.CAN-11-3015 pubmed: 22461510 pmcid: 4641440
Chae, Y. C. et al. Mitochondrial Akt regulation of hypoxic tumor reprogramming. Cancer Cell 30, 257–272. https://doi.org/10.1016/j.ccell.2016.07.004 (2016).
doi: 10.1016/j.ccell.2016.07.004 pubmed: 27505672 pmcid: 5131882
Boyineni, J. et al. Inorganic polyphosphate as an energy source in tumorigenesis. Oncotarget 11, 4613–4624. https://doi.org/10.18632/oncotarget.27838 (2020).
doi: 10.18632/oncotarget.27838 pubmed: 33400735 pmcid: 7747861
Kuroda, A. A polyphosphate-lon protease complex in the adaptation of Escherichia coli to amino acid starvation. Biosci. Biotechnol. Biochem. 70, 325–331. https://doi.org/10.1271/bbb.70.325 (2006).
doi: 10.1271/bbb.70.325 pubmed: 16495646
Lu, B. Mitochondrial Lon protease and cancer. Adv. Exp. Med. Biol. 1038, 173–182. https://doi.org/10.1007/978-981-10-6674-0_12 (2017).
doi: 10.1007/978-981-10-6674-0_12 pubmed: 29178076
Rogerson, D. T. et al. Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog. Nat. Chem. Biol. 11, 496–503. https://doi.org/10.1038/nchembio.1823 (2015).
doi: 10.1038/nchembio.1823 pubmed: 26030730 pmcid: 4830402
Xie, J., Supekova, L. & Schultz, P. G. A genetically encoded metabolically stable analogue of phosphotyrosine in Escherichia coli. ACS Chem. Biol. 2, 474–478. https://doi.org/10.1021/cb700083w (2007).
doi: 10.1021/cb700083w pubmed: 17622177
Kunova, N. et al. The role of Lon-mediated proteolysis in the dynamics of mitochondrial nucleic acid-protein complexes. Sci. Rep. 7, 631. https://doi.org/10.1038/s41598-017-00632-8 (2017).
doi: 10.1038/s41598-017-00632-8 pubmed: 28377575 pmcid: 5428876
Schneider, C. A., Rasband, W. S. & Eliceiri, K. W. NIH image to IMAGEJ: 25 years of image analysis. Nat. Methods 9, 671–675. https://doi.org/10.1038/nmeth.2089 (2012).
doi: 10.1038/nmeth.2089 pubmed: 22930834 pmcid: 5554542
Lanzetta, P. A., Alvarez, L. J., Reinach, P. S. & Candia, O. A. An improved assay for nanomole amounts of inorganic phosphate. Anal. Biochem. 100, 95–97. https://doi.org/10.1016/0003-2697(79)90115-5 (1979).
doi: 10.1016/0003-2697(79)90115-5 pubmed: 161695
Kumble, K. D. & Kornberg, A. Inorganic polyphosphate in mammalian cells and tissues. J. Biol. Chem. 270, 5818–5822. https://doi.org/10.1074/jbc.270.11.5818 (1995).
doi: 10.1074/jbc.270.11.5818 pubmed: 7890711
Menon, A. S. & Goldberg, A. L. Protein substrates activate the ATP-dependent protease La by promoting nucleotide binding and release of bound ADP. J. Biol. Chem. 262, 14929–14934 (1987).
doi: 10.1016/S0021-9258(18)48117-3 pubmed: 3312197
Gibellini, L. et al. Silencing of mitochondrial Lon protease deeply impairs mitochondrial proteome and function in colon cancer cells. FASEB J. 28, 5122–5135. https://doi.org/10.1096/fj.14-255869 (2014).
doi: 10.1096/fj.14-255869 pubmed: 25154874
Suzuki, C. K., Suda, K., Wang, N. & Schatz, G. Requirement for the yeast gene LON in intramitochondrial proteolysis and maintenance of respiration. Science 264, 891. https://doi.org/10.1126/science.8178144 (1994).
doi: 10.1126/science.8178144 pubmed: 8178144
Bernstein, S. H. et al. The mitochondrial ATP-dependent Lon protease: A novel target in lymphoma death mediated by the synthetic triterpenoid CDDO and its derivatives. Blood 119, 3321–3329. https://doi.org/10.1182/blood-2011-02-340075 (2012).
doi: 10.1182/blood-2011-02-340075 pubmed: 22323447 pmcid: 3321858
Krissinel, E. & Henrick, K. Inference of macromolecular assemblies from crystalline state. J. Mol. Biol. 372, 774–797. https://doi.org/10.1016/j.jmb.2007.05.022 (2007).
doi: 10.1016/j.jmb.2007.05.022 pubmed: 17681537
Kulakovskaya, E. V., Zemskova, M. Y. & Kulakovskaya, T. V. Inorganic polyphosphate and cancer. Biochemistry (Mosc) 83, 961–968. https://doi.org/10.1134/S0006297918080072 (2018).
doi: 10.1134/S0006297918080072 pubmed: 30208832
Pavlov, E. et al. Inorganic polyphosphate and energy metabolism in mammalian cells. J. Biol. Chem. 285, 9420–9428. https://doi.org/10.1074/jbc.M109.013011 (2010).
doi: 10.1074/jbc.M109.013011 pubmed: 20124409 pmcid: 2843191
Gray, M. J. Inorganic polyphosphate accumulation in Escherichia coli is regulated by DksA but not by (p)ppGpp. J. Bacteriol. 201, 10–1128. https://doi.org/10.1128/JB.00664-18 (2019).
doi: 10.1128/JB.00664-18
Gray, M. J. & Jakob, U. Oxidative stress protection by polyphosphate–new roles for an old player. Curr. Opin. Microbiol. 24, 1–6. https://doi.org/10.1016/j.mib.2014.12.004 (2015).
doi: 10.1016/j.mib.2014.12.004 pubmed: 25589044 pmcid: 4380828
Rao, N. N., Gomez-Garcia, M. R. & Kornberg, A. Inorganic polyphosphate: Essential for growth and survival. Annu. Rev. Biochem. 78, 605–647. https://doi.org/10.1146/annurev.biochem.77.083007.093039 (2009).
doi: 10.1146/annurev.biochem.77.083007.093039 pubmed: 19344251
Rao, N. N., Liu, S. & Kornberg, A. Inorganic polyphosphate in Escherichia coli: The phosphate regulon and the stringent response. J. Bacteriol. 180, 2186–2193. https://doi.org/10.1128/JB.180.8.2186-2193.1998 (1998).
doi: 10.1128/JB.180.8.2186-2193.1998 pubmed: 9555903 pmcid: 107147
Kuroda, A. et al. Role of inorganic polyphosphate in promoting ribosomal protein degradation by the Lon protease in E. coli. Science 293, 705–708. https://doi.org/10.1126/science.1061315 (2001).
doi: 10.1126/science.1061315 pubmed: 11474114
Grasso, D., Zampieri, L. X., Capeloa, T., Van de Velde, J. A. & Sonveaux, P. Mitochondria in cancer. Cell Stress 4, 114–146. https://doi.org/10.15698/cst2020.06.221 (2020).
doi: 10.15698/cst2020.06.221 pubmed: 32548570 pmcid: 7278520
Ishikawa, K. et al. ROS-generating mitochondrial DNA mutations can regulate tumor cell metastasis. Science 320, 661–664. https://doi.org/10.1126/science.1156906 (2008).
doi: 10.1126/science.1156906 pubmed: 18388260
Missiroli, S., Perrone, M., Genovese, I., Pinton, P. & Giorgi, C. Cancer metabolism and mitochondria: Finding novel mechanisms to fight tumours. EBioMedicine 59, 102943. https://doi.org/10.1016/j.ebiom.2020.102943 (2020).
doi: 10.1016/j.ebiom.2020.102943 pubmed: 32818805 pmcid: 7452656
Young, T. S., Ahmad, I., Yin, J. A. & Schultz, P. G. An enhanced system for unnatural amino acid mutagenesis in E. coli. J. Mol. Biol. 395, 361–374. https://doi.org/10.1016/j.jmb.2009.10.030 (2010).
doi: 10.1016/j.jmb.2009.10.030 pubmed: 19852970
Ambro, L. et al. Mutations to a glycine loop in the catalytic site of human Lon changes its protease, peptidase and ATPase activities. FEBS J. 281, 1784–1797. https://doi.org/10.1111/febs.12740 (2014).
doi: 10.1111/febs.12740 pubmed: 24520911
van Dijl, J. M. et al. The ATPase and protease domains of yeast mitochondrial Lon: Roles in proteolysis and respiration-dependent growth. Proc. Natl. Acad. Sci. U S A 95, 10584–10589. https://doi.org/10.1073/pnas.95.18.10584 (1998).
doi: 10.1073/pnas.95.18.10584 pubmed: 9724747 pmcid: 27938
Michalski, A. et al. Ultra high resolution linear ion trap Orbitrap mass spectrometer (Orbitrap Elite) facilitates top down LC MS/MS and versatile peptide fragmentation modes. Mol. Cell Proteom. 11, O111. https://doi.org/10.1074/mcp.O111.013698 (2012).
doi: 10.1074/mcp.O111.013698
Cox, J. & Mann, M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 26, 1367–1372. https://doi.org/10.1038/nbt.1511 (2008).
doi: 10.1038/nbt.1511 pubmed: 19029910
Colaert, N., Helsens, K., Martens, L., Vandekerckhove, J. & Gevaert, K. Improved visualization of protein consensus sequences by iceLogo. Nat. Methods 6, 786–787. https://doi.org/10.1038/nmeth1109-786 (2009).
doi: 10.1038/nmeth1109-786 pubmed: 19876014
Mastronarde, D. N. Automated electron microscope tomography using robust prediction of specimen movements. J. Struct. Biol. 152, 36–51. https://doi.org/10.1016/j.jsb.2005.07.007 (2005).
doi: 10.1016/j.jsb.2005.07.007 pubmed: 16182563
Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: Algorithms for rapid unsupervised cryo-EM structure determination. Nat. Methods 14, 290–296. https://doi.org/10.1038/nmeth.4169 (2017).
doi: 10.1038/nmeth.4169 pubmed: 28165473
Vagin, A. & Teplyakov, A. Molecular replacement with MOLREP. Acta Crystallogr. D Biol. Crystallogr. 66, 22–25. https://doi.org/10.1107/S0907444909042589 (2010).
doi: 10.1107/S0907444909042589 pubmed: 20057045
Afonine, P. V. et al. Real-space refinement in PHENIX for cryo-EM and crystallography. Acta Crystallogr. D Struct. Biol. 74, 531–544. https://doi.org/10.1107/S2059798318006551 (2018).
doi: 10.1107/S2059798318006551 pubmed: 29872004 pmcid: 6096492
Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. Acta Crystallogr. D Biol. Crystallogr. 66, 486–501. https://doi.org/10.1107/S0907444910007493 (2010).
doi: 10.1107/S0907444910007493 pubmed: 20383002 pmcid: 2852313
Liebschner, D. et al. Macromolecular structure determination using X-rays, neutrons and electrons: Recent developments in Phenix. Acta Crystallogr. D Struct. Biol. 75, 861–877. https://doi.org/10.1107/S2059798319011471 (2019).
doi: 10.1107/S2059798319011471 pubmed: 31588918 pmcid: 6778852
Williams, C. J. et al. MolProbity: More and better reference data for improved all-atom structure validation. Protein Sci. 27, 293–315. https://doi.org/10.1002/pro.3330 (2018).
doi: 10.1002/pro.3330 pubmed: 29067766
Baker, N. A., Sept, D., Joseph, S., Holst, M. J. & McCammon, J. A. Electrostatics of nanosystems: Application to microtubules and the ribosome. Proc. Natl. Acad. Sci. U S A 98, 10037–10041. https://doi.org/10.1073/pnas.181342398 (2001).
doi: 10.1073/pnas.181342398 pubmed: 11517324 pmcid: 56910
Schrödinger, L. The PyMOL molecular graphics system, Version 2.5.0.

Auteurs

Nina Kunová (N)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.

Gabriela Ondrovičová (G)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.

Jacob A Bauer (JA)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.

Veronika Krajčovičová (V)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Laboratory of Clinical and Molecular Genetics, National Institute of Children's Diseases, Limbová 1, 833 40, Bratislava, Slovakia.

Matyáš Pinkas (M)

CEITEC, Masaryk University in Brno, Brno, Czech Republic.

Barbora Stojkovičová (B)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.
Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic.

Henrieta Havalová (H)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.

Veronika Lukáčová (V)

Medirex Group Academy, Nitra, Slovakia.

Lenka Kohútová (L)

Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.

Július Košťan (J)

Department of Structural and Computational Biology, Max Perutz Labs, University of Vienna, Campus Vienna, Biocenter 5, 1030, Vienna, Austria.

Lucia Martináková (L)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia.

Peter Baráth (P)

Medirex Group Academy, Nitra, Slovakia.
Institute of Chemistry, Slovak Academy of Sciences, Bratislava, Slovakia.

Jiří Nováček (J)

CEITEC, Masaryk University in Brno, Brno, Czech Republic.

Sebastian Zoll (S)

Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo Namesti 542/2, 16000, Prague, Czech Republic.

Sami Kereϊche (S)

Institute of Biology and Medical Genetics, First Faculty of Medicine, Charles University in Prague, Prague, Czech Republic. skere@lf1.cuni.cz.
Institute of Organic Chemistry and Biochemistry of the Czech Academy of Sciences, Flemingovo Namesti 542/2, 16000, Prague, Czech Republic. skere@lf1.cuni.cz.

Eva Kutejová (E)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia. eva.kutejova@savba.sk.

Vladimír Pevala (V)

Department of Biochemistry and Protein Structure, Institute of Molecular Biology, Slovak Academy of Sciences, Dúbravská Cesta 21, 845 51, Bratislava, Slovakia. vladimir.pevala@savba.sk.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH